Citations

Showing 10 of 108094 citations.

eQTL Set–Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma
Wang, Xiaoyu , Gharahkhani, Puya , Levine, David , Fitzgerald, Rebecca C. , Corley, Douglas A. , Risch, Harvey A. , Bernstein, Leslie , Chow, Wong‐Ho , Onstad, Lynn , Shaheen, Nicholas J. , Lagergren, Jesper , Hardie, Laura J. , Wu, Anna H. , Liu, Geoffrey , Anderson, Lesley , Iyer, Prasad G. , Gammon, Marilie D. , Caldas, Carlos , Ye, Weimin , Barr, Hugh , Harrison, Rebecca , Watson, R.G. Peter , Attwood, Stephen , Chegwidden, Laura , Love, Sharon , MacDonald, David , Prenen, Hans , Ott, Katja , Lang, Hauke , Mayershofer, Rupert , Knapp, Michael , Veits, Lothar , Gerges, Christian , Weismüller, Josef , Reeh, Matthias , Nöthen, Markus M. , Izbicki, Jakob R. , Manner, Hendrik , Neuhaus, Horst , Böhmer, Anne C. , Hölscher, Arnulf H. , Anders, Mario , Pech, Oliver , Schumacher, Brigitte , Schmidt, Claudia , Noder, Tania , Lorenz, Dietmar , Vieth, Michael , May, Andrea , Kreuser, Nicole , Becker, Jessica , Ell, Christian , Tomlinson, Ian , Palles, Claire , Whiteman, David C. , MacGregor, Stuart , Schumacher, Johannes , Vaughan, Thomas L. , Buas, Matthew F. , Dai, James Y. , Levine, David M , Gockel, Ines , Corley, Douglas A , Risch, Harvey A , Bernstein, Leslie , Chow, Wong-Ho , Onstad, Lynn , Shaheen, Nicholas J , Lagergren, Jesper , Hardie, Laura J , Wu, Anna H. , Pharoah, Paul D P , Liu, Geoffrey , Anderson, Lesley A , Iyer, P G , Caldas, Carlos , Ye, Weimin , Barr, Hugh , Moayyedi, Paul , Harrison, Rebecca , Watson, R G Peter , Attwood, Stephen , Chegwidden, Laura , Love, Sharon B , MacDonald, David , deCaestecker, John , Prenen, Hans , Ott, Katja , Moebus, Susanne , Venerito, Marino , Lang, Hauke , Mayershofer, Rupert , Knapp, Michael , Veits, Lothar , Gerges, Christian , Weismüller, Josef , Reeh, Matthias , Nöthen, Markus M , Izbicki, Jakob R , Manner, Hendrik , Neuhaus, Horst , Rösch, Thomas , Böhmer, Anne C , Hölscher, Arnulf H , Anders, Mario , Pech, Oliver , Schumacher, Brigitte , Schmidt, Claudia , Schmidt, Thomas , Noder, Tania , Lorenz, Dietmar , Vieth, Michael , May, Andrea , Hess, Timo , Kreuser, Nicole , Becker, Jessica , Ell, Christian , Tomlinson, Ian , Palles, Claire , Jankowski, Janusz A , Whiteman, David C , MacGregor, Stuart , Schumacher, Johannes , Vaughan, Thomas L , Buas, Matthew F , Dai, James Y , Gharahkhani, Puya , Pharoah, Paul D.P. , Moayyedi, Paul , Caestecker, John de , Moebus, Susanne , Hess, Timo , Jankowski, Janusz

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | June 16, 2022 | Volume: 31 | Issue: 9 | Pages: 1735-1745

10.1158/1055-9965.epi-22-0096 | PMID 35709760 Get It

Abstract Background: Over 20 susceptibility single-nucleotide polymorphisms (SNP) have been identified for esophageal adenocarcinoma (EAC) and its precursor, Barrett esophagus (BE), explaining a small portion of heritability. Methods: Using genetic data from 4,323 BE and 4,116 EAC patients aggregated by international consortia including the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON), we conducted a comprehensive transcriptome-wide association study (TWAS) for BE/EAC, leveraging Genotype Tissue Expression (GTEx) gene-expression data from six tissue types of plausible relevance to EAC etiology: mucosa and muscularis from the esophagus, gastroesophageal (GE) junction, stomach, whole blood, and visceral adipose. Two analytical approaches were taken: standard TWAS using the predicted gene expression from local expression quantitative trait loci (eQTL), and set-based SKAT association using selected eQTLs that predict the gene expression. Results: Although the standard approach did not identify significant signals, the eQTL set–based approach identified eight novel associations, three of which were validated in independent external data (eQTL SNP sets for EXOC3, ZNF641, and HSP90AA1). Conclusions: This study identified novel genetic susceptibility loci for EAC and BE using an eQTL set–based genetic association approach. Impact: This study expanded the pool of genetic susceptibility loci for EAC and BE, suggesting the potential of the eQTL set–based genetic association approach as an alternative method for TWAS analysis.
Germ Line Fanconi Anemia Complementation Group C Mutations and Pancreatic Cancer
Johnson, Michele R., Boardman, Lisa, Petersen, Gloria M. , Couch, Fergus J. , Rabe, Kari G. , Boardman, Lisa, McWilliams, Robert R. , Andrade, Mariza de

Mayo Clinic

Cancer Research | June 16, 2022 | Volume: 65 | Issue: 2 | Pages: 383-386

10.1158/0008-5472.383.65.2 Get It

Abstract Biallelic mutations in Fanconi anemia complementation group genes disrupt DNA repair and result in the complex Fanconi anemia phenotype. In addition, germ line mutations in the BRCA2/FANCD1 Fanconi anemia complementation group gene have also been implicated in predisposition to a number of cancers including pancreatic cancer. The recent identification of FANCC and FANCG mutations in resected pancreatic tumors selected for loss of heterozygosity on chromosome 9, some of which were present in the germ line DNA, suggests that inactivation of these and other Fanconi complementation group genes may contribute to pancreatic cancer. To further assess the relevance of FANCC and FANCG mutations to pancreatic cancer we conducted a mutation screen of these genes in DNA from blood of 421 sequentially collected pancreatic cancer cases diagnosed at the Mayo Clinic. Two truncating FANCC mutations but no truncating FANCG mutations were identified in young onset (<55 years) pancreatic cancer cases with no family history of pancreatic cancer. Both mutations were associated with loss of heterozygosity of the wild-type allele in corresponding pancreatic tumors. In addition, no truncating mutations were identified in germ line DNA from blood of 658 control individuals undergoing routine colonoscopy. Taken together these data support the assertion that inherited mutations in FANCC can predispose to pancreatic cancer.
P32: Treatment of LVAD drive line infections with absorbable antibiotic beads.
Wadiwala, Ishaq , Alamouti-fard, Emad, Sareyyüpoğlu, Başar , Landolfo, Kevin , Pham, Si M.

Mayo Clinic

ASAIO Journal | June 16, 2022 | Volume: 68 | Issue: Supplement 2 | Pages: 108-108

10.1097/01.mat.0000841344.52757.b8 Get It

REN3: Percutaneous Axillary Temporary Mechanical Support Improves Renal Function Prior To Heart Transplantation In Patients With Chronic Kidney Disease
Jang, Ji-Min, Nativí, Jose, Patel, Parag C. , Leoni, Juan , Yip, Daniel , Sareyyüpoğlu, Başar , Landolfo, Kevin , Leoni, Juan Carlos , Pham, Si M. , Goswami, Rohan

Mayo Clinic

ASAIO Journal | June 16, 2022 | Volume: 68 | Issue: Supplement 2 | Pages: 89-89

10.1097/01.mat.0000841208.11864.3b Get It

Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity
Hirano, Fumiya, Kaneko, Katsumi , Tamura, Hideto , Wang, Shengdian , Rietz, Cecilia, Flies, Dallas B. , Lau, Julie S., Zhu, Gefeng, Tamada, Koji , Kaneko, Katsumi, Dong, Haidong , Ichikawa, Masao, Chen, Lieping

Mayo Clinic

Cancer Research | June 16, 2022 | Volume: 65 | Issue: 3 | Pages: 1089-1096

10.1158/0008-5472.1089.65.3 Get It

Abstract Contemporary approaches for vaccination and immunotherapy are often capable of eliciting strong T-cell responses against tumor antigens. However, such responses are not parallel to clinical tumor regression. The development of evasion mechanisms within tumor microenvironment may be responsible for poor therapeutic responses. We report here that constitutive or inducible expression of B7-H1, a B7 family molecule widely expressed by cancers, confers resistance to therapeutic anti-CD137 antibody in mice with established tumors. The resistance is accompanied with failure of antigen-specific CD8+ CTLs to destroy tumor cells without impairment of CTL function. Blockade of B7-H1 or PD-1 by specific monoclonal antibodies could reverse this resistance and profoundly enhance therapeutic efficacy. Our findings support that B7-H1/PD-1 forms a molecular shield to prevent destruction by CTLs and implicate new approaches for immunotherapy of human cancers.
Functional Evaluation and Cancer Risk Assessment of BRCA2 Unclassified Variants
Wu, Kangjian, Hinson, Shannon R., Ohashi, Akihiro , Farrugia, Daniel J., Wendt, Patricia, Tavtigian, Sean V. , Deffenbaugh, Amie M., Goldgar, David E., Couch, Fergus J.

Mayo Clinic

Cancer Research | June 16, 2022 | Volume: 65 | Issue: 2 | Pages: 417-426

10.1158/0008-5472.417.65.2 Get It

Abstract The influence of germ line BRCA2 unclassified variants (UCV), including missense mutations and in-frame deletions and insertions on BRCA2 function and on cancer risk, has not been defined although these mutations account for 43% of all identified BRCA2 sequence alterations. To investigate the effects of UCVs on BRCA2 function, we compared mutant and wild-type forms of BRCA2 using assays of cellular survival and viability, homologous recombination repair, and genome instability. We confirm that the effects of known deleterious mutations can be distinguished from neutral polymorphisms and wild-type BRCA2 in these assays, and we characterize the influence of a series of UCVs on BRCA2 function. We also describe how the results from the assays can be combined with data from analysis of cosegregation of the UCVs with cancer, co-occurrence of the UCVs with other deleterious mutations, and interspecies sequence variation in a comprehensive framework in an effort to better distinguish between disease predisposing and neutral UCVs. This combined approach represents a useful means of addressing the functional significance and cancer relevance of UCVs in BRCA2.
Quantitative Neuromuscular Monitoring: “Love All, Trust a Few, Do Wrong to None”
Brull, Sorin J. , Brull, Sorin J , Fülesdi, Béla

Mayo Clinic

Anesthesia & Analgesia | June 16, 2022 | Volume: 135 | Issue: 1 | Pages: 35-38

10.1213/ane.0000000000006035 | PMID 35709442 Get It

Temporal lobe interictal spikes disrupt encoding and retrieval of verbal memory: A subregion analysis
Camarillo‐Rodriguez, Liliana , Leenen, Iwin , Waldman, Zachary, Serruya, Mijail D. , Wanda, Paul A., Herweg, Nora A. , Kahana, Michael J. , Orosz, Iren, Podkorytova, Irina , Jobst, Barbara C. , Sheth, Sameer A. , Weiss, Shennan A. , Sperling, Michael R. , Podkorytova, Irina , Weiss, Shennan A , Sperling, Michael R , Jobst, Barbara , Rubinstein, Daniel , Lega, Bradley Charles , Gross, Robert E. , Worrell, Gregory A. , Davis, Kathryn A.

Mayo Clinic

Epilepsia | June 16, 2022 | Volume: 63 | Issue: 9 | Pages: 2325-2337

10.1111/epi.17334 | PMID 35708911 Get It

AbstractObjectiveThe medial temporal lobe (MTL) encodes and recalls memories and can be a predominant site for interictal spikes (IS) in patients with focal epilepsy. It is unclear whether memory deficits are due to IS in the MTL producing a transient decline. Here, we investigated whether IS in the MTL subregions and lateral temporal cortex impact episodic memory encoding and recall.MethodsSeventy‐eight participants undergoing presurgical evaluation for medically refractory focal epilepsy with depth electrodes placed in the temporal lobe participated in a verbal free recall task. IS were manually annotated during the pre‐encoding, encoding, and recall epochs. We examined the effect of IS on word recall using mixed‐effects logistic regression.ResultsIS in the left hippocampus (odds ratio [OR] = .73, 95% confidence interval [CI] = .63–.84, p < .001) and left middle temporal gyrus (OR = .46, 95% CI = .27–.78, p < .05) during word encoding decreased subsequent recall performance. Within the left hippocampus, this effect was specific for area CA1 (OR = .76, 95% CI = .66–.88, p < .01) and dentate gyrus (OR = .74, 95% CI = .62–.89, p < .05). IS in other MTL subregions or inferior and superior temporal gyrus and IS occurring during the prestimulus window did not affect word encoding (p > .05). IS during retrieval in right hippocampal (OR = .22, 95% CI = .08–.63, p = .01) and parahippocampal regions (OR = .24, 95% CI = .07–.8, p < .05) reduced the probability of recalling a word.SignificanceIS in medial and lateral temporal cortex contribute to transient memory decline during verbal episodic memory.
Utilization of skin biopsy for diagnosis in a case of Lafora disease
Rozenova, Krasimira , Lehman, Julia S. , Grande, Joseph P. , Fine, Anthony L. , Wieland, Carilyn N. , Rozenova, Krasimira A , Fine, Anthony , Lehman, Julia S

Mayo Clinic

Journal of Cutaneous Pathology | June 16, 2022 | Volume: 49 | Issue: 10 | Pages: 885-888

10.1111/cup.14275 | PMID 35708461 Get It

AbstractLafora disease is a rare inherited neurodegenerative disease with onset in adolescence. Patients present with progressive myoclonic seizures and cognitive decline. The disease is linked to mutations in either of the two genes encoding malin and laforin, and it is associated with the accumulation of polyglucosan inclusions (Lafora bodies [LBs]) in various tissues, such as brain, liver, muscle, and skin, with the skin being particularly accessible for biopsy. Histopathologic examination of affected tissue with demonstration of LBs, together with the presence of pathologic mutation in EPM2A or NHLRC1 genes, is sufficient for diagnosis of this neurologic disorder when clinically suspected. Here, we report the case of a 16‐year‐old female with progressive neurologic symptoms and homozygous mutation in the NHLRC1 gene encoding malin. The skin biopsy was instrumental in reaching the final diagnosis by showing LBs in sweat glands by histopathologic and electron microscopic examination.
Long-term Outcomes in Patients with Adult-Onset Craniopharyngioma
Bedatsova, Lucia, Donegan, Diane , Erickson, Dana , Dogra, Prerna , Gompel, Jamie J. Van , Giannini, Caterina

Mayo Clinic

No container title available | June 16, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1731920/v1 Get It

Abstract Purpose Craniopharyngiomas are nonmalignant sellar and parasellar tumors exhibiting a bimodal age distribution. While the outcomes following treatment in patients with childhood-onset craniopharyngiomas are well characterized, similar information in adult-onset craniopharyngiomas is limited. We aimed to describe the long-term outcomes (weight and metabolic parameters, mortality) in patients with adult-onset craniopharyngioma following treatment. Methods: Patients with adult-onset craniopharyngioma with initial treatment (1993–2017) and > 6 months of follow-up at our institution were retrospectively identified. Body mass index (BMI) categories included obese (BMI ≥ 30 kg/m2), overweight (BMI 25-29.9 kg/m2), and normal weight (BMI < 25 kg/m2). Results For the 91 patients with adult-onset craniopharyngioma (44% women, mean diagnosis age 48.2 ± 18 years) over a mean follow-up of 100.3 ± 69.5 months, weight at last follow-up was significantly higher than before surgery (mean difference 9.5 ± 14.8 kg, P < 0.001) with a higher percentage increase in weight seen in those with lower preoperative BMI [normal weight (20.7 ± 18%) vs. overweight (13.3 ± 18.0%) vs. obese (6.4 ± 15%), P = 0.012. At last follow-up, the prevalence of obesity (62 vs. 40.5%, P = 0.0042) and impaired glucose metabolism (17.4% vs. 34%, P = 0.017) increased significantly. All-cause mortality was 12%, with the average age of death 71.9 ± 19.7 years (average U.S. life expectancy 77.7 years, CDC 2020). Conclusion Patients with adult-onset craniopharyngioma following treatment may experience weight gain, increased prevalence of obesity, impaired glucose metabolism, and early mortality. Lower preoperative BMI is associated with a greater percentage increase in postoperative weight.